Osama E. Rahma

Also affiliated with AstraZeneca (United States)

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile

4.5Author DataRank

Indexed papers

6in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 6 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Composition, Spatial Characteristics, and Prognostic Significance of Myeloid Cell Infiltration in Pancreatic Cancer

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-3141

Top 5%

4.5DataRank

Top 5%159 citations

Jinming Zhang, Chen Yuan, Juha P. Väyrynen, Andressa Dias Costa, Hannah L. Williams +24 more

Papers

Driven by 32 papers — median percentile 0. Top paper: “Composition, Spatial Characteristics, and Prognostic Significance of Myeloid Cell Infiltration in Pancreatic Cancer”.

Composition, Spatial Characteristics, and Prognostic Significance of Myeloid Cell Infiltration in Pancreatic Cancer

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-3141

Top 5%

4.5DataRank

Top 5%159 citations

Jinming Zhang, Chen Yuan, Juha P. Väyrynen, Andressa Dias Costa, Hannah L. Williams +24 more

The positive effect of immune checkpoint inhibitor-induced thyroiditis on overall survival accounting for immortal time bias: a retrospective cohort study of 6596 patients

Annals of Oncology(2021)10.1016/j.annonc.2021.05.357

N/A

2.0DataRank · unranked

42 citations

Donald F. Chute, Ian A. Strohbehn, Sophia Zhao, Michelle Rengarajan, Alexander T. Faje +13 more

Safety, tolerability and efficacy of agonist anti-CD27 antibody (varlilumab) administered in combination with anti-PD-1 (nivolumab) in advanced solid tumors

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2022-005147

N/A

1.7DataRank · unranked

66 citations

Michael J. Pishvaian, Margaret K. Callahan, Amy Weise, Branimir I. Šikić, Osama E. Rahma +19 more

Molecular Pathways of Colon Inflammation Induced by Cancer Immunotherapy

Cell(2020)10.1016/j.cell.2020.06.001

N/A

0.927DataRank · unranked

481 citations

Shengbao Suo, Hannah L. Williams, Tatyana Sharova, Keri M. Sullivan, Michael P. Manos +11 more

Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor

Cancer Immunology Research(2024)10.1158/2326-6066.cir-23-1073

N/A

0.840DataRank · unranked

30 citations

Andressa Dias Costa, Emily Kawaler, Victoire Cardot‐Ruffino, Osama E. Rahma, Nina Beri +36 more

Efficacy, safety, and biomarker analyses of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with advanced non-small cell lung cancer

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2023-008480

N/A

0.612DataRank · unranked

19 citations

Houssein Abdul Sater, Osama E. Rahma, Richy Agajanian, Wiem Lassoued, Jennifer L. Marté +13 more

Outcomes after resumption of immune checkpoint inhibitor therapy after high‐grade immune‐mediated hepatitis

Cancer(2020)10.1002/cncr.33165

N/A

0.598DataRank · unranked

53 citations

Jordan Sack, Osama E. Rahma, F. Stephen Hodi, Stephen D. Zucker, Shilpa Grover +1 more

Long-term results from NRG-GI002: A phase II clinical trial platform using total neoadjuvant therapy (TNT) in locally advanced rectal cancer (LARC).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.7

N/A

0.561DataRank · unranked

41 citations

Greg Yothers, Osama E. Rahma, Theodore S. Hong, Marcia M. Russell, Y. Nancy You +14 more

Multicenter randomized controlled trial of neoadjuvant chemoradiotherapy alone or in combination with pembrolizumab in patients with resectable or borderline resectable pancreatic adenocarcinoma

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2023-007586

N/A

0.546DataRank · unranked

37 citations

Gina R. Petroni, Todd W. Bauer, Matthew J. Reilley, Brian M. Wolpin, Chee‐Chee Stucky +14 more

A phase 1b study of nivolumab in patients with autoimmune disorders and advanced malignancies (AIM-NIVO).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.tps2676

N/A

0.510DataRank · unranked

29 citations

Michael Dougan, Sarthak Gupta, Laura C. Cappelli, Tamiko R. Katsumoto, Osama E. Rahma +15 more

Safety and Efficacy of Immune Checkpoint Inhibitors in Patients on Dialysis: A Retrospective Case Series

American Journal of Kidney Diseases(2020)10.1053/j.ajkd.2020.02.451

N/A

0.477DataRank · unranked

23 citations

Meghan Lee, Harish Seethapathy, Donald F. Chute, Osama E. Rahma, Amanda C. Guidon +7 more

Circulating KRAS G12D but not G12V is associated with survival in metastatic pancreatic ductal adenocarcinoma

Nature Communications(2024)10.1038/s41467-024-49915-5

N/A

0.396DataRank · unranked

13 citations

Lee McDaniel, Changgee Chang, Qi Long, Shannon M. Pfeiffer, Jaclyn P. Lyman +37 more

Safety and effectiveness of combination versus monotherapy with immune checkpoint inhibitors in patients with preexisting autoimmune diseases

OncoImmunology(2023)10.1080/2162402x.2023.2261264

N/A

0.330DataRank · unranked

8 citations

Sabina Sandigursky, Juhee Song, María A. López-Olivo, Houssein Safa, Samuel Cytryn +12 more

A Phase I Trial of Trebananib, an Angiopoietin 1 and 2 Neutralizing Peptibody, Combined with Pembrolizumab in Patients with Advanced Ovarian and Colorectal Cancer

Cancer Immunology Research(2024)10.1158/2326-6066.cir-23-1027

N/A

0.292DataRank · unranked

6 citations

Osama E. Rahma, Kevin Tyan, Yvonne Li, Anita Giobbie‐Hurder, Benjamin L. Schlechter +18 more

Baseline level and early on-treatment clearance of circulating mutant KRAS in metastatic pancreatic ductal adenocarcinoma treated with chemotherapy with or without immunotherapy.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.4122

N/A

0.104DataRank · unranked

1 citations

Aseel Abdalla, Neha Bhagwat, Taylor A. Black, Zhuoyang Wang, Stephanie S. Yee +15 more

Germline variants associated with immunotherapy-related adverse events

medRxiv(2022)10.1101/2022.04.10.22273627

N/A

0DataRank · unranked

0 citations

Sarah Abou Alaiwi, Wenxin Xu, Vivek Naranbhai, Amin H. Nassar, Ziad Bakouny +26 more

NRG-GI002: A phase II clinical trial platform using total neoadjuvant therapy (TNT) in locally advanced rectal cancer (LARC)—Pembrolizumab experimental arm (EA) primary results.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.3_suppl.8

N/A

0DataRank · unranked

32 citations

Greg Yothers, Theodore S. Hong, Marcia M. Russell, Y. Nancy You, William Parker +10 more

Molecular profiling and treatment pattern differences between intrahepatic and extrahepatic cholangiocarcinoma

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad046

N/A

0DataRank · unranked

28 citations

Leontios Pappas, Islam Baiev, Jordan R. Maurer, Andrea Grace Bocobo, Karen Zhang +25 more

PD-1 Blockade Induces Reactivation of Nonproductive T-Cell Responses Characterized by NF-κB Signaling in Patients with Pancreatic Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1444

N/A

0DataRank · unranked

27 citations

Patrick J. Lenehan, Victoire Cardot‐Ruffino, Andressa Dias Costa, Matthew H. G. Katz, Todd W. Bauer +16 more

Immune checkpoint inhibitor–induced thyroiditis is a risk factor for acute and chronic kidney dysfunction

Nephrology Dialysis Transplantation(2021)10.1093/ndt/gfab240

N/A

0DataRank · unranked

2 citations

Sarah E. Street, Donald F. Chute, Harish Seethapathy, Meghan Lee, Rituvanthikaa Seethapathy +7 more

Durable clinical benefit from PARP inhibition in a platinum-sensitive, BRCA2-mutated pancreatic cancer patient after earlier progression on placebo treatment on the POLO trial: a case report

Journal of Gastrointestinal Oncology(2021)10.21037/jgo-21-197

N/A

0DataRank · unranked

4 citations

Brian M. Wolpin, Ilana S. Warsofsky, David P. Ryan, Kimberly Perez, Osama E. Rahma +7 more

Data from A Randomized Trial of Combined PD-L1 and CTLA-4 Inhibition with Targeted Low-Dose or Hypofractionated Radiation for Patients with Metastatic Colorectal Cancer

(2023)10.1158/1078-0432.c.6531336

Top 100%

0DataRank

Top 100%0 citations

Anita Giobbie‐Hurder, Ana Lako, Emily M. Thrash, Ryan Brennick, Katrina Kao +29 more

Data from A Randomized Trial of Combined PD-L1 and CTLA-4 Inhibition with Targeted Low-Dose or Hypofractionated Radiation for Patients with Metastatic Colorectal Cancer

(2023)10.1158/1078-0432.c.6531336.v1

Top 100%

0DataRank

Top 100%0 citations

Anita Giobbie‐Hurder, Ana Lako, Emily M. Thrash, Ryan Brennick, Katrina Kao +29 more

Supplementary Data from First-in-Human Phase I/II ICONIC Trial of the ICOS Agonist Vopratelimab Alone and with Nivolumab: ICOS-High CD4 T-Cell Populations and Predictors of Response

Figshare(2023)10.1158/1078-0432.22487576.v1

Top 100%

0DataRank

Top 100%0 citations

Justin F. Gainor, Margaret K. Callahan, Gerald S. Falchook, Russell K. Pachynski, Patricia LoRusso +29 more

Data from Composition, Spatial Characteristics, and Prognostic Significance of Myeloid Cell Infiltration in Pancreatic Cancer

(2023)10.1158/1078-0432.c.6530165

Top 100%

0DataRank

Top 100%0 citations

Jinming Zhang, Chen Yuan, Juha P. Väyrynen, Andressa Dias Costa, Hannah L. Williams +24 more

Data from Composition, Spatial Characteristics, and Prognostic Significance of Myeloid Cell Infiltration in Pancreatic Cancer

(2023)10.1158/1078-0432.c.6530165.v1

Top 100%

0DataRank

Top 100%0 citations

Jinming Zhang, Chen Yuan, Juha P. Väyrynen, Andressa Dias Costa, Hannah L. Williams +24 more

Leveraging longitudinal clinical annotations and panel sequencing to characterize dynamics of organotropism in metastatic melanoma.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.9526

N/A

0DataRank · unranked

0 citations

Michael P. Manos, William Ge, Giuseppe Tarantino, Xue Bai, Osama E. Rahma +5 more

Immune-related adverse events and kidney function decline in patients with genitourinary cancers treated with immune checkpoint inhibitors

European Journal of Cancer(2021)10.1016/j.ejca.2021.07.031

N/A

0DataRank · unranked

16 citations

Sarah E. Street, Ian A. Strohbehn, Meghan Lee, Sophia H. Zhao, Nifasha Rusibamayila +16 more

Incidence and Predictors of CKD and Estimated GFR Decline in Patients Receiving Immune Checkpoint Inhibitors

American Journal of Kidney Diseases(2021)10.1053/j.ajkd.2021.05.012

N/A

0DataRank · unranked

30 citations

Sophia Zhao, Ian A. Strohbehn, Nifasha Rusibamayila, Harish Seethapathy, Meghan Lee +9 more

A phase Ib study of nivolumab in patients with autoimmune disorders and advanced malignancies (AIM-NIVO).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps3158

N/A

0DataRank · unranked

6 citations

María E. Suarez‐Almazor, Jeane Painter, Tanner M. Johanns, Michael Dougan, Laura C. Cappelli +15 more

First-in-Human Phase I/II ICONIC Trial of the ICOS Agonist Vopratelimab Alone and with Nivolumab: ICOS-High CD4 T-Cell Populations and Predictors of Response

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-4256

N/A

0DataRank · unranked

98 citations

Justin F. Gainor, Margaret K. Callahan, Gerald S. Falchook, Russell K. Pachynski, Patricia LoRusso +29 more

Gastroparesis Following Immune Checkpoint Inhibitor Therapy: A Case Series

Digestive Diseases and Sciences(2020)10.1007/s10620-020-06440-x

N/A

0DataRank · unranked

18 citations

Jordan Sack, Richard Thomas, Osama E. Rahma, Michael Camilleri, Shilpa Grover +1 more

Osama E. Rahma

Indexed papers

Top data-sharing exemplar

Papers